BLS Global Equities’s Mead Johnson Nutrition Company MJN Stock Holding History

BLS Global Equities’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$11.7M	Buy	+165,690	New	+$12.3M	3.94%	12

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

BLS Global Equities's MJN Position: Q4 2016 in Review

BLS Global Equities opened a new position in Mead Johnson Nutrition Company (MJN) in Q4 2016: 165,690 shares worth $11.7M. The stake represents 3.94% of the portfolio and ranks #12 among its holdings.

553 funds tracked by Wall St. Rank hold MJN as of Q4 2016.

BLS Global Equities held 165,690 shares of Mead Johnson Nutrition Company worth $11.7M as of Q4 2016.
Mead Johnson Nutrition Company was a new BLS Global Equities position in Q4 2016.
Mead Johnson Nutrition Company made up 3.94% of BLS Global Equities's portfolio in Q4 2016, its #12 holding.
553 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2016.

Based on BLS Global Equities's 13F filing for Q4 2016, filed 9 Feb 2017.